Filter
834
Text search:
vaccine
trial
Featured
Recommendations
91
New Publications
166
Language
Document type
No document type
351
Studies & Reports
175
Guidelines
155
Manuals
44
Fact sheets
41
Strategic & Response Plan
25
Training Material
15
Situation Updates
11
Resource Platforms
10
Videos
4
Brochures
1
App
1
Infographics
1
Countries / Regions
Global
41
India
28
Sierra Leone
18
Kenya
18
South Africa
17
Liberia
13
Uganda
13
West and Central Africa
13
Western and Central Europe
13
Brazil
12
East and Southern Africa
11
Africa
11
Russia
10
Ethiopia
9
Eastern Europe
9
Nigeria
8
Ghana
8
Zambia
8
Latin America and the Carribbean
8
Congo, Democratic Republic of
7
Philippines
7
South Sudan
7
Tanzania
7
Guinea
6
Zimbabwe
6
Rwanda
6
Nepal
5
Bangladesh
5
Mozambique
5
Middle East and North Africa
5
Germany
4
Malawi
4
Ukraine
4
Myanmar / Burma
4
Syria
3
Cambodia
3
Paraguay
3
Asia
3
Jordan
2
Lebanon
2
Thailand
2
Indonesia
2
Argentina
2
Namibia
2
Angola
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Burkina Faso
1
Guinea-Bissau
1
USA
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Turkey
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Botswana
1
Chile
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
France
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
210
Clinical Guidelines
108
Women & Child Health
56
Public Health
35
Key Resources
18
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
COVID-19
196
TB
74
HIV
67
Ebola & Marburg
51
NTDs
51
AMR
20
Malaria
20
Rapid Response
16
Pharmacy
15
Mental Health
14
Planetary Health
11
Global Health Education
10
Health Financing Toolbox
10
NCDs
10
Cholera
9
Refugee
8
Polio
7
Zika
7
Caregiver
6
2.0 Rapid Response
6
Conflict
5
Disability
2
Natural Hazards
1
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pa
...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
WHO Secretariat Information paper July 2016
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of
...
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
Updated 28 December 2020
Presentation OPT-SMC malaria vaccine workshop - Jan 2023
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and a
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
AstraZeneca-SKBio in South Korea and Serum Institute of India
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include
...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.